Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

Press releases published on July 10, 2026

Jul. 10, 2026

La Croix-Rouge canadienne met sur pied un fonds de secours pour aider les personnes touchées par les inondations au Manitoba

Indeterminate GlobeNewswire

Jul. 10, 2026

GuideAI Health Announces Marketing and Communications Programs

Indeterminate GlobeNewswire

Jul. 10, 2026

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 10, 2026

VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister

Indeterminate GlobeNewswire

Jul. 10, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 10, 2026

Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 10, 2026

Elevar Therapeutics Receives FDA Complete Response Letter for Combination of Rivoceranib and Camrelizumab as a First-line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

Indeterminate GlobeNewswire

Jul. 10, 2026

AB Science fait le point sur son programme clinique avec l’arrêt de certaines études cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques

Indeterminate GlobeNewswire

Jul. 10, 2026

FDA Proposes Rule to Modernize Drug Manufacturing Registration

Indeterminate GlobeNewswire

Jul. 10, 2026

Microscopy Market to Grow from USD 8.81 Billion in 2025 to USD 11.44 Billion by 2031, at a CAGR of 5.5% – MarketsandMarkets™

Indeterminate GlobeNewswire

Jul. 10, 2026

PatchMD Adds a Topical Berberine Patch to Its Lineup

Indeterminate GlobeNewswire

Jul. 10, 2026

Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector

Indeterminate GlobeNewswire

Jul. 10, 2026

Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative

Indeterminate GlobeNewswire

Jul. 10, 2026

SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders

Indeterminate GlobeNewswire

Jul. 10, 2026

Dubai Health and Rush University System for Health Announce Strategic Collaboration to Advance Quality of Care

Indeterminate GlobeNewswire

Jul. 10, 2026

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

Jul. 10, 2026

Frishantic Launches Vitamin D3 K2 5000 IU Supplement for Indoor-Heavy Lifestyles

Indeterminate GlobeNewswire

Jul. 10, 2026

BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities

Indeterminate GlobeNewswire

Jul. 10, 2026

Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials

Indeterminate GlobeNewswire

Jul. 10, 2026

BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire